New Developments in Type 2 Diabetes Management: Fixed-Ratio Combination Treatment with Basal Insulin and GLP-1 Receptor Agonists


What is the Rationale for Fixed-Ratio Combinations of Basal Insulin Analogs and GLP-1 Receptor Agonists?
Format: Expert Interview

Please click the link below to register and view the webinar.

https://reachmd.com/programs/cme/what-is-rationale-fixed-ratio-combinations-basal-insulin-analogs-and-glp-1-receptor-agonists/8627/


To register and view the other available on-demand activities in this series, click on the links below:

How Fixed-Ratio Combinations Are Individualizing Type 2 Diabetes Treatment
Format: Expert Case Review
https://reachmd.com/programs/cme/how-fixed-ratio-combinations-are-individualizing-type-2-diabetes-treatment/8628

How to Administer Fixed-Ratio Combinations of GLP-1 Receptor Agonists & Basal Insulin
Format: Panel Discussion and Device Demonstration Video
https://reachmd.com/programs/cme/how-to-administer-fixed-ratio-combinations-glp-1-receptor-agonists-basal-insulin/8629/

Series Page:
https://reachmd.com/cme/fixed-ratio-combination-treatment-basal-insulin-and-glp-1-receptor-agonists/

For questions regarding your CE credit please contact us at 845-398-5949.